Small Intestinal Adenocarcinoma
Oncology
Prevalence
0.5 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ramucirumab | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Small Intestinal Adenocarcinoma?
BioSniper tracks 1 drug in development for Small Intestinal Adenocarcinoma across 1 company.
How many clinical trials target Small Intestinal Adenocarcinoma?
There are 1 clinical trial targeting Small Intestinal Adenocarcinoma tracked by BioSniper.
What is the prevalence of Small Intestinal Adenocarcinoma?
The estimated prevalence of Small Intestinal Adenocarcinoma is approximately 0.5 per 100,000 population.
Deep-dive into Small Intestinal Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis